Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

The influence of short-chain essential fatty acids on children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study.

Raz R, Carasso RL, Yehuda S.

J Child Adolesc Psychopharmacol. 2009 Apr;19(2):167-77. doi: 10.1089/cap.2008.070.

PMID:
19364294
2.

The effects of essential fatty acid supplementation by Efamol in hyperactive children.

Aman MG, Mitchell EA, Turbott SH.

J Abnorm Child Psychol. 1987 Mar;15(1):75-90.

PMID:
3553274
3.

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.

Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE, Sutton VK, Gonzales J, Malcolm SK, Schuh KJ, Allen AJ.

Pediatrics. 2004 Jul;114(1):e1-8.

PMID:
15231966
4.

The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension.

Manor I, Magen A, Keidar D, Rosen S, Tasker H, Cohen T, Richter Y, Zaaroor-Regev D, Manor Y, Weizman A.

Eur Psychiatry. 2012 Jul;27(5):335-42. doi: 10.1016/j.eurpsy.2011.05.004. Epub 2011 Jul 31.

PMID:
21807480
5.

Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial.

Widenhorn-Müller K, Schwanda S, Scholz E, Spitzer M, Bode H.

Prostaglandins Leukot Essent Fatty Acids. 2014 Jul-Aug;91(1-2):49-60. doi: 10.1016/j.plefa.2014.04.004. Epub 2014 May 28.

PMID:
24958525
6.

A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study.

Biederman J, Swanson JM, Wigal SB, Boellner SW, Earl CQ, Lopez FA; Modafinil ADHD Study Group..

J Clin Psychiatry. 2006 May;67(5):727-35.

PMID:
16841622
7.
9.

Supplementation with flax oil and vitamin C improves the outcome of Attention Deficit Hyperactivity Disorder (ADHD).

Joshi K, Lad S, Kale M, Patwardhan B, Mahadik SP, Patni B, Chaudhary A, Bhave S, Pandit A.

Prostaglandins Leukot Essent Fatty Acids. 2006 Jan;74(1):17-21. Epub 2005 Nov 28.

PMID:
16314082
10.

Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review.

Raz R, Gabis L.

Dev Med Child Neurol. 2009 Aug;51(8):580-92. doi: 10.1111/j.1469-8749.2009.03351.x. Epub 2009 Jun 22. Review.

11.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
12.
13.
14.

Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.

Simonoff E, Taylor E, Baird G, Bernard S, Chadwick O, Liang H, Whitwell S, Riemer K, Sharma K, Sharma SP, Wood N, Kelly J, Golaszewski A, Kennedy J, Rodney L, West N, Walwyn R, Jichi F.

J Child Psychol Psychiatry. 2013 May;54(5):527-35. doi: 10.1111/j.1469-7610.2012.02569.x. Epub 2012 Jun 7.

PMID:
22676856
15.

Does zinc moderate essential fatty acid and amphetamine treatment of attention-deficit/hyperactivity disorder?

Arnold LE, Pinkham SM, Votolato N.

J Child Adolesc Psychopharmacol. 2000 Summer;10(2):111-7.

PMID:
10933121
16.

Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder.

Burgess JR, Stevens L, Zhang W, Peck L.

Am J Clin Nutr. 2000 Jan;71(1 Suppl):327S-30S. Review.

17.

Randomized, double-blind trial of guanfacine extended release in children with attention-deficit/hyperactivity disorder: morning or evening administration.

Newcorn JH, Stein MA, Childress AC, Youcha S, White C, Enright G, Rubin J.

J Am Acad Child Adolesc Psychiatry. 2013 Sep;52(9):921-30. doi: 10.1016/j.jaac.2013.06.006. Epub 2013 Aug 1.

PMID:
23972694
18.
19.

A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder.

Greenhill LL, Findling RL, Swanson JM; ADHD Study Group..

Pediatrics. 2002 Mar;109(3):E39.

PMID:
11875167
20.

A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.

Biederman J, Melmed RD, Patel A, McBurnett K, Konow J, Lyne A, Scherer N; SPD503 Study Group..

Pediatrics. 2008 Jan;121(1):e73-84. doi: 10.1542/peds.2006-3695.

PMID:
18166547

Supplemental Content

Support Center